Condition
PPA
Total Trials
6
Recruiting
3
Active
3
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (2)
P 1 (1)
P 2 (1)
P 4 (1)
Trial Status
Recruiting3
Completed2
Enrolling By Invitation1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07316413Not ApplicableRecruiting
Repetitive Transcranial Magnetic Stimulation in Frontotemporal Lobar Degeneration
NCT04680130Enrolling By Invitation
Clinico-Pathologic-Genetic-Imaging Study of Neurodegenerative and Related Disorders
NCT01818661Phase 4RecruitingPrimary
Longitudinal Multi-Modality Imaging in Progressive Apraxia of Speech
NCT05742698Phase 2Recruiting
Nabilone for Agitation in Frontotemporal Dementia
NCT03728582Not ApplicableCompleted
Rehabilitating and Decelerating Language Loss in Primary Progressive Aphasia With tDCS Plus Language Therapy
NCT01623284Phase 1CompletedPrimary
PiB PET Scanning in Speech and Language Based Dementias
Showing all 6 trials